These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke
The new service delivers end-to-end support, managing every stage of an epigenomics project
Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
Pangea will use its integrated validation platform and regulatory expertise to oversee analytical and clinical validation of Gene Solutions’ multi-omics technologies.
The new functionality complements Parse’s existing Evercode immune products
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
The partnership initially will focus on cardiovascular and kidney diseases
Subscribe To Our Newsletter & Stay Updated
